News

Ichor Publishes Article Unraveling Evolutionary Mechanisms of Phase Separation Proteins in Extreme Microorganisms
Ichor Publishes Article Unraveling Evolutionary Mechanisms of Phase Separation Proteins in Extreme Microorganisms Lafayette, N.Y. – September 8, 2022 – Ichor Life

LENTO BIO RAISES $680,000 IN OVERSUBSCRIBED SEED ROUND LED BY ICHOR LIFE SCIENCES
LENTO BIO RAISES $680,000 IN OVERSUBSCRIBED SEED ROUND LED BY ICHOR LIFE SCIENCES Potsdam, N.Y. – September 6, 2022 – Lento Bio,

ICHOR LIFE SCIENCES INVESTS $1.5 MILLION IN MITOCHEM THERAPEUTICS FOR OCULAR AGING DISEASE RESEARCH
ICHOR LIFE SCIENCES INVESTS $1.5 MILLION IN MITOCHEM THERAPEUTICS FOR OCULAR AGING DISEASE RESEARCH LaFayette, N.Y. – August 11, 2022 – Ichor

Lento Bio, Inc. Appoints Two Ichor Life Sciences Executives as a Member of the Board of Directors and Scientific Advisors
Lento Bio, Inc. Appoints Two Ichor Life Sciences Executives as a Member of the Board of Directors and Scientific Advisors Potsdam, N.Y.

ICHOR LIFE SCIENCES EXPANDS OPHTHALMOLOGY CAPABILITIES WITH CHRISTOPHER SCHILLO’S APPOINTMENT AS VIVARIUM DIRECTOR
ICHOR LIFE SCIENCES EXPANDS OPHTHALMOLOGY CAPABILITIES WITH CHRISTOPHER SCHILLO’S APPOINTMENT AS VIVARIUM DIRECTOR LaFayette, N.Y. – Ichor Life Sciences, a premium pre-clinical

LENTO BIO, AN ICHOR LIFE SCIENCES PORTFOLIO COMPANY, LAUNCHES WITH AIMS TO DEVELOP ANTI-GLYCATION DRUGS FOR PRESBYOPIA AND DISEASES OF AGING
LENTO BIO, AN ICHOR LIFE SCIENCES PORTFOLIO COMPANY, LAUNCHES WITH AIMS TO DEVELOP ANTI-GLYCATION DRUGS FOR PRESBYOPIA AND DISEASES OF AGING Potsdam,